Enzon Pharmaceuticals Inc (ENZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 28,795 | 18,150 | -2,783 | -20,763 | 177,243 |
| Depreciation Amortization | N/A | 1,160 | 7,846 | 7,442 | 8,977 |
| Other Working Capital | 3,604 | -3,226 | -9,301 | -2,364 | 7,744 |
| Other Operating Activity | -61 | -2,079 | 12,690 | 2,960 | -171,349 |
| Operating Cash Flow | $32,338 | $14,005 | $8,452 | $-12,725 | $22,615 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 151 | 2,234 | -14 | -626 | -1,967 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 262,581 |
| Purchase Of Investment | N/A | N/A | -208,267 | -263,061 | -2,834 |
| Sale Of Investment | N/A | 118,894 | 305,838 | 104,448 | 86,306 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -105 |
| Investing Cash Flow | $151 | $121,128 | $97,557 | $-159,239 | $343,981 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -115,849 | -13,862 | -5,000 | N/A |
| Common Stock Issued | N/A | -21 | 106 | 5,706 | 32,107 |
| Common Stock Repurchased | N/A | N/A | -31,744 | -120,793 | -48,170 |
| Dividend Paid | -4,417 | -89,808 | -87,348 | N/A | N/A |
| Other Financing Activity | -30 | -283 | -137 | -1,155 | -3,443 |
| Financing Cash Flow | $-4,447 | $-205,961 | $-132,985 | $-121,242 | $-19,506 |
| Beginning Cash Position | 6,520 | 77,348 | 104,324 | 397,530 | 50,440 |
| End Cash Position | 34,562 | 6,520 | 77,348 | 104,324 | 397,530 |
| Net Cash Flow | $28,042 | $-70,828 | $-26,976 | $-293,206 | $347,090 |
| Free Cash Flow | |||||
| Operating Cash Flow | 32,338 | 14,005 | 8,452 | -12,725 | 22,615 |
| Capital Expenditure | N/A | N/A | -23 | -630 | -1,967 |
| Free Cash Flow | 32,338 | 14,005 | 8,429 | -13,355 | 20,648 |